2006
DOI: 10.1016/j.ejpain.2005.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of mu‐opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials

Abstract: short-term studies show that opioids can reduce the intensity of dynamic mechanical allodynia and perhaps of cold allodynia in peripheral NP. Insufficient evidence precludes drawing conclusions regarding the effect of opioids on other forms of evoked NP. A meta-analysis of intermediate-term studies demonstrates the efficacy of opioids over placebo for evoked NP. These findings are clinically relevant because dynamic mechanical allodynia and cold allodynia are the most prevalent types of evoked pain in NP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
42
0
5

Year Published

2006
2006
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 81 publications
(49 citation statements)
references
References 30 publications
(86 reference statements)
2
42
0
5
Order By: Relevance
“…This is no longer tenable -neuropathic pain can be relieved by opioids, although it is very likely that relief is obtained only with doses larger than those commonly used for the relief of inflammatory pain and that their efficacy against stimulus-evoked neuropathic pain may be limited (20,21).…”
Section: Treatment Responsesmentioning
confidence: 99%
“…This is no longer tenable -neuropathic pain can be relieved by opioids, although it is very likely that relief is obtained only with doses larger than those commonly used for the relief of inflammatory pain and that their efficacy against stimulus-evoked neuropathic pain may be limited (20,21).…”
Section: Treatment Responsesmentioning
confidence: 99%
“…8 Opiates are also used and have reported efficacy. 9,10 In the past several years, many other targets/agents have been implicated, but assertions of their efficacy must be considered, dependent on the still evolving data sets.…”
Section: Introductionmentioning
confidence: 99%
“…-18 to -10; p<0.001). 15 The overall NNT of opioids for neuropathic pain is 2.5 (CI 2.0-3.2). Secondary outcome parameters such as physical and mental health, sleep and disability were measured in parts of these trials and yielded inconsistent results.…”
mentioning
confidence: 99%